Incidence of infectious diseases is higher in children and adolescents with rheumatic diseases than in the general population due to disease activity, possible immune deficiency secondary to the disease itself, or the use of immunosuppressive drugs. Vaccination is effective in reducing morbidity and mortality in those patients. The objective of this study was to establish an evidence-based consensus on the efficacy and safety of vaccination in children and adolescents with rheumatic diseases. Passive immunization of patients and guidelines for people who live with immunosuppressed patients were also included. The 32 pediatric rheumatologists of the Rheumatology Department of the Pediatrics Society of São Paulo, (SPSP, from the Portuguese), São Paulo, SP, Brazil, and/or the Commission on Pediatrics Rheumatology of the Brazilian Society of Rheumatology are responsible for this consensus; some of those professionals are involved on research and scientific publications in this field. The words efficacy and/or safety of different vaccines in children and adolescents with rheumatologic diseases were searched in Medline and Scielo data bases from 1966 to March 2009, including reviews, controlled studies, and case reports. The degree of recommendation and the scientific evidence of the studies were classified in four levels for each vaccine. As a rule, inactive and protein components vaccines are safe for patients with rheumatologic diseases, even in the presence of immunosuppressive therapy. However, live attenuated vaccines are, in general, contraindicated for immunosuppressed patients.495562589Doran, M.F., Crowson, C.S., Pond, G.R., O'Fallon, W.M., Gabriel, S.E., Frequency of infection in patients with rheumatoid arthritis compared with controls: A population-based study (2002) Arthritis Rheum, 46, pp. 2287-2293Gluck, T., Kiefmann, B., Grohmann, M., Falk, W., Straub, R.H., Scholmerich, J., Immune status and risk for infection in patients receiving chronic immunosuppressive therapy (2005) Journal of Rheumatology, 32 (8), pp. 1473-1480Gluck, T., Muller-Ladner, U., Vaccination in patients with chronic rheumatic or autoimmune diseases (2008) Clinical Infectious Diseases, 46 (9), pp. 1459-1465. , DOI 10.1086/587063Campos-Outcalt, D., Immunization update: Latest recommendations from the CDC (2007) Journal of Family Practice, 56 (5), pp. 377-380Facó, M.M., Nukumizu, L.A., Pantoja, A.J., Barros, P.C., Troster, E.J., Silva, C.A., Avaliação dos Óbitos e Necropsias em Pacientes Internados em um Serviço de Reumatologia Pediátrica por um Período de Dez Anos (2005) Rev Bras Reumatol, 45, pp. 55-63Davies, K., Woo, P., Immunization in rheumatic diseases of childhood: An audit of the clinical practice of british paediatric rheumatology group members and a review of the evidence (2002) Rheumatology, 41 (8), pp. 937-941Snowden, N., (2007) Immunisation of Immunosuppressed Patients with Rheumatic Diseases, , www.arc.org.uk/arthinfo/medpub/6632/6632.asp, citedLuz, K.R., Souza, D.C., Ciconelli, R.M., Vacinação em pacientes imunossuprimidos e com doenças reumatológicas autoimunes (2007) Rev Bras Reumatol, 47, pp. 106-113Conti, F., Rezai, S., Valesini, G., Vaccination and autoimmune rheumatic diseases (2008) Autoimmunity Reviews, 8, pp. 124-128Atzeni, F., Bendtzen, K., Bobbio-Pallavicini, F., Conti, F., Cutolo, M., Montecucco, C., Sulli, A., Sarzi-Puttini, P., Infections and treatment of patients with rheumatic diseases (2008) Clinical and Experimental Rheumatology, 26 (1 SUPPL. 48), pp. S67-S73Varicella-zoster infections circunstances (2005) Red Book, pp. 672-686. , American Academy of Pediatrics. Committee of Infectious Diseases. LK P, editor. 27th ed. Elk Grove Village, ILCutolo, M., Seriolo, B., Pizzorni, C., Use of glucocorticoids and risk of infections (2008) Autoimmun Rev, 8, pp. 153-155Cooke, A., Ferraccioli, G.F., Herrmann, M., Induction and protection of autoimmune rheumatic diseases. the role of infections (2008) Clin Exp Rheumatol, 26, pp. S1-7(2005) Hepatites Virais: O Brasil Está Atento / Ministério Da Saúde, Secretaria de Vigilância Em Saúde, Departamento de Vigilância Epidemiológica, , Brasília: Ministério da SaúdeBerry, P.A., Smith-Laing, G., Hepatitis A vaccine associated with autoimmune hepatitis (2007) World J Gastroenterol, 13, pp. 2238-2239De Carvalho, J.F., Shoenfeld, Y., Status epilepticus and lymphocytic pneumonitis following hepatitis B vaccination (2008) European Journal of Internal Medicine, 19 (5), pp. 383-385. , DOI 10.1016/j.ejim.2007.10.005, PII S0953620507002944De Carvalho, J.F., Shoenfeld, Y., Status epilepticus and lymphocytic pneumonitis following hepatitis B vaccination (2008) European Journal of Internal Medicine, 19 (5), pp. 383-385. , DOI 10.1016/j.ejim.2007.10.005, PII S0953620507002944Kuruma, K.A.M., Borba, E.F., Lopes, M.H., De Carvalho, J.F., Bonfa, E., Safety and efficacy of hepatitis B vaccine in systemic lupus erythematosus (2007) Lupus, 16 (5), pp. 350-354. , DOI 10.1177/0961203307078225Geier, D.A., Geier, M.R., A case-control study of serious autoimmune adverse events following hepatitis B immunization (2005) Autoimmunity, 38, pp. 295-301Geier, M.R., Geier, D.A., A case-series of adverse events, positive re-challenge of symptoms, and events in identical twins following hepatitis B vaccination: Analysis of the Vaccine Adverse Event Reporting System (VAERS) database and literature review (2004) Clin Exp Rheumatol, 22, pp. 749-755Schattner, A., Consequence or coincidence? the occurrence, pathogenesis and significance of autoimmune manifestations after viral vaccines (2005) Vaccine, 23 (30), pp. 3876-3886. , DOI 10.1016/j.vaccine.2005.03.005, PII S0264410X05003506Cooper, G.S., Dooley, M.A., Treadwell, E.L., St Clair, E.W., Gilkeson, G.S., Risk factors for development of systemic lupus erythematosus: Allergies, infections, and family history (2002) J Clin Epidemiol, 55, pp. 982-989Moxey-Mims, M.M., Preston, K., Fivush, B., McCurdy, F., Heptavax-B in pediatric dialysis patients: Effect of systemic lupus erythematosus (1990) Pediatric Nephrology, 4 (2), pp. 171-173Kasapcopur, O., Cullu, F., Kamburoolu-Goksel, A., Cam, H., Akdenizli, E., Calykan, S., Sever, L., Arysoy, N., Hepatitis B vaccination in children with juvenile idiopathic arthritis (2004) Annals of the Rheumatic Diseases, 63 (9), pp. 1128-1130. , DOI 10.1136/ard.2003.013201Baseman, J.G., Koutsky, L.A., The epidemiology of human papillomavirus infections (2005) J Clin Virol, 32 (SUPPL. 1), pp. S16-S24Block, S.L., Nolan, T., Sattler, C., Comparison of the Immunogenicity and Reactogenicity of a Prophylactic Quadrivalent Human Papillomavirus (Types 6, 11, 16, and 18) L1 Virus-Like Particle Vaccine in Male and Female Adolescents and Young Adult Women (2006) Pediatrics, 118, pp. 2135-2145. , Protocol 016 Study GroupGarland, S.M., Hernandez-Avila, M., Wheeler, C.M., Females United to Unilaterally Reduce Endo/Ectocervical Disease (FUTURE) I Investigators. Quadrivalent Vaccine against Human Papillomavirus to Prevent Anogenital Diseases (2007) N Engl J Med, 356, pp. 1928-1943Villa, L.L., Perez, G., Kjaer, S.K., Paavonen, J., Lehtinen, M., Munoz, N., Sigurdsson, K., Thornton, A.R., Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions (2007) New England Journal of Medicine, 356 (19), pp. 1915-1927. , http://content.nejm.org/cgi/reprint/356/19/1915.pdf, DOI 10.1056/NEJMoa061741Dhar, J.P., Essenmacher, L., Ager, J., Sokol, R.J., Ominous cervical cytopathology in women with lupus (2005) International Journal of Gynecology and Obstetrics, 89 (3), pp. 295-296. , DOI 10.1016/j.ijgo.2005.02.006, PII S0020729205001608Febronio, M.V., Pereira, R.M.R., Bonfa, E., Takiuti, A.D., Pereyra, E.A.G., Silva, C.A.A., Inflammatory cervicovaginal cytology is associated with disease activity in juvenile systemic lupus erythematosus (2007) Lupus, 16 (6), pp. 430-435. , DOI 10.1177/0961203307079298Centers for Disease Control and Prevention, , www.cdc.orgBekker, A., Chou, C., Bernstein, H.H., Update on universal annual influenza immunization recommendations for children (2009) Curr Opin Pediatr, 21, pp. 122-126Abu-Shakra, M., Press, J., Buskila, D., Sukenik, S., Influenza vaccination of patients with systemic lupus erythematosus: Safety and immunogenecity issues (2007) Autoimmunity Reviews, 6 (8), pp. 543-546. , DOI 10.1016/j.autrev.2006.12.004, PII S1568997206002199, Special Issue on: The skin and Autoimmune Rheumatic DiseasesAbu-Shakra, M., Press, J., Varsano, N., Levy, V., (2002) Specific Antibody Response after Influenza Immunization in Systemic Lupus Erythematosus J Rheumatol, 29, pp. 2555-2557Holvast, B., Huckriede, A., Kallenberg, C.G., Bijl, M., Influenza vaccination in systemic lupus erythematosus: Safe and protective? (2007) Autoimmun Rev, 6, pp. 300-305Holvast, A., Huckriede, A., Wilschut, J., Safety and efficacy of influenza vaccination in systemic lupus erythematosus patients with quiescent disease (2006) Ann Rheum Dis, 65, pp. 913-918Brodman, R., Gilfillan, R., Glass, D., Schur, P.H., Influenzal vaccine response in systemic lupus erythematosus (1978) Annals of Internal Medicine, 88 (6), pp. 735-740Louie, J.S., Nies, K.M., Shoji, K.T., Clinical and antibody responses after influenza immunization in systemic lupus erythematosus (1978) Annals of Internal Medicine, 88 (6), pp. 790-792Malleson, P.N., Tekano, J.L., Scheifele, D.W., Weber, J.M., Influenza immunization in children with chronic arthritis: A prospective study (1993) J Rheumatol, 20, pp. 1769-1773Kanakoudi-Tsakalidou, F., Trachana, M., Pratsidou-Gertsi, P., Tsitsami, E., Kyriazopoulou-Dalaina, V., Influenza vaccination in children with chronic rheumatic diseases and long-term immunosuppressive therapy (2001) Clinical and Experimental Rheumatology, 19 (5), pp. 589-594Elkayam, O., Ablin, J., Caspi, D., Safety and efficacy of vaccination against streptococcus pneumonia in patients with rheumatic diseases (2007) Autoimmunity Reviews, 6 (5), pp. 312-314. , DOI 10.1016/j.autrev.2006.09.005, PII S1568997206001467McCann, L.J., Should children under treatment for juvenile idiopathic arthritis receive flu vaccination? (2007) Arch Dis Child, 92, pp. 366-368Hess, E.V., Hahn, V., Influenza immunization in lupus erythematosus: Safe, effective? (1978) Ann Intern Med, 88, pp. 833-834Abu-Shakra, M., Zalmanson, S., Neumann, L., Flusser, D., Sukenik, S., Buskila, D., Influenza virus vaccination of patients with systemic lupus erythematosus: Effects on disease activity (2000) Journal of Rheumatology, 27 (7), pp. 1681-1685Abu-Shakra, M., Press, J., Sukenik, S., Buskila, D., Influenza virus vaccination of patients with SLE: Effects on generation of autoantibodies (2002) Clin Rheumatol, 21, pp. 369-372Faco, M.M.M., Leone, C., Campos, L.M.A., Febronio, M.V., Marques, H.H.S., Silva, C.A., Risk factors associated with the death of patients hospitalized for juvenile systemic lupus erythematosus (2007) Brazilian Journal of Medical and Biological Research, 40 (7), pp. 993-1002. , http://www.scielo.br/scielo.php?script=sci_arttext&pid= S0100-879X2007000700015&lng=en&nrm=iso&tlng=enMeisel, R., Kuypers, L., Dirksen, U., Schubert, R., Gruhn, B., Strauss, G., Beutel, K., Dilloo, D., Pneumococcal conjugate vaccine provides early protective antibody responses in children after related and unrelated allogeneic hematopoietic stem cell transplantation (2007) Blood, 109 (6), pp. 2322-2326. , http://bloodjournal.hematologylibrary.org/cgi/reprint/109/6/2322, DOI 10.1182/blood-2006-06-032284Lin, P.L., Michaels, M.G., Green, M., Safety and immunogenicity of the American Academy of Pediatrics recommended sequential pneumococcal conjugate and polysaccharide vaccine schedule in pediatric solid organ transplant recipients (2005) Pediatrics, 116, pp. 160-167Kapetanovic, M.C., Saxne, T., Sjöholm, A., Truedsson, L., Jönsson, G., Geborek, P., Influence of methotrexate, TNF blockers and prednisolone on antibody responses to pneumococcal polysaccharide vaccine in patients with rheumatoid arthritis (2006) Rheumatology (Oxford), 45, pp. 106-111Mease, P.J., Ritchlin, C.T., Martin, R.W., Gottlieb, A.B., Baumgartner, S.W., Burge, D.J., Whitmore, J.B., Pneumococcal vaccine response in psoriatic arthritis patients during treatment with etanercept (2004) Journal of Rheumatology, 31 (7), pp. 1356-1361Battafarano, D.F., Battafarano, N.J., Larsen, L., Dyer, P.D., Older, S.A., Muehlbauer, S., Hoyt, A., Enzenauer, R.J., Antigen-specific antibody responses in lupus patients following immunization (1998) Arthritis and Rheumatism, 41 (10), pp. 1828-1834. , DOI 10.1002/1529-0131(199810)41:10<1828::AID-ART15>3.0.CO;2-TKarsh, J., Pavlidis, N., Schiffman, G., Moutsopoulos, H.M., Immunization of patients with Sjogren's syndrome with pneumococcal polysaccharide vaccine (1980) Arthritis and Rheumatism, 23 (11), pp. 1294-1298. , DOI 10.1002/art.1780231111Klippel, J.H., Karsh, J., Stahl, N.I., A controlled study of pneumococcal polysaccharide vaccine in systemic lupus erythematosus (1979) Arthritis and Rheumatism, 22 (12), pp. 1321-1325. , DOI 10.1002/art.1780221201Elkayam, O., Ablin, J., Caspi, D., Safety and efficacy of vaccination against streptococcus pneumonia in patients with rheumatic diseases (2007) Autoimmunity Reviews, 6 (5), pp. 312-314. , DOI 10.1016/j.autrev.2006.09.005, PII S1568997206001467Ridgway, D., Wolff, L.J., Active immunization of children with leukemia and other malignancies (1993) Leukemia and Lymphoma, 9 (3), pp. 177-192Brezinschek, H.P., Hofstaetter, T., Leeb, B.F., Haindl, P., Graninger, W.B., Immunization of patients with rheumatoid arthritis with antitumor necrosis factor alpha therapy and methotrexate (2008) Curr Opin Rheumatol, 20, pp. 295-299Centers for Disease Control and Prevention. Preventing Pneumococcal Disease among Infants and Young Children (2000) MMWR, 49 (NO RR-9), pp. 1-35. , Recommendations of the Advisory Committee on Immunization Practices (ACIP)Centers for Disease Control and Prevention. Prevention and control of meningococcal disease (2005) MMWR, 54 (NO RR-7). , recommendations of the Advisory Committee on Immunization Practices (ACIP)Zonneveld-Huijssoon, E., Ronaghy, A., Van Rossum, M.A.J., Rijkers, G.T., Van Der Klis, F.R.M., Sanders, E.A.M., Vermeer-De Bondt, P.E., Wulffraat, N.M., Safety and efficacy of meningococcal C vaccination in juvenile idiopathic arthritis (2007) Arthritis and Rheumatism, 56 (2), pp. 639-646. , DOI 10.1002/art.22399Immunization in special clinical circumstances (2003) 2003 Red Book, pp. 54-81. , American Academy of Pediatrics. Pickering LK, editor. Report of the Committee on Infectious Diseases. 26th Ed. Elk Grove Vilage: American Academy of Pediatrics(2006) Secretaria de Vigilância Em Saúde, , Hib: Brasil. Ministério da Saúde. Departamento de Vigilância e Epidemiologia, Programa Nacional de Imunizações. Manual dos Centros de Referência para Imunobiológicos Especiais (CRIES)Mota, L.M., Oliveira, A.C., Lima, R.A., Santos-Neto, L.L., Tauil, P.L., Vaccination against yellow fever among patients on imunossupressors with diagnoses of rheumatic diseases (2009) Rev Soc Bras Med Trop, 42, pp. 23-27(2008) Wkly Epidemiol Rec, 83, pp. 287-292. , Global Advisory Committee on vaccine safety Dec 2007(2008) Wkly Epidemiol Rec, 83, pp. 285-292. , Joint WHO-CDC Conference on laboratory quality systems, Lyon, April 2008- joint statement and recommendations(2001) Manual de Normas de Vacinação, , Brasil. Ministério da Saúde. Fundação Nacional de Saúde. 3. ed. Brasília: Ministério da SaúdeColditz, G.A., Berkey, C.S., Mosteller, F., The efficacy of Calmette- Guérin vaccination of newborns and infants in the prevention of tuberculosis: Meta-analysis of the published literature (1995) Pediatrics, 96, pp. 29-35Wunsh Filho, V., De Castilho, E.A., Rodrigues, L.C., Huttly, S.R., Effectiveness of BCG vaccination against tuberculous meningitis: A case-control study in São Paulo, Brazil (1990) Bull Word Health Organ, 68, pp. 69-74Camargos, P.A.M., Guimarães, M.D.C., Antunes, C.M.F., Risk assessment for acquiring meningitis tuberculosis among children not vaccinated with BCG: A case control study (1988) Int J Epidemiol, 17, pp. 193-197Barreto, M.B., Cunha, S.S., Pereira, S.M., BCG neonatal protects children and young adults against all forms tuberculosis in Brazil (2005) Int J Tuberc Lung Dis., 10, pp. 1171-1173(2007) Vigilância Em Saúde Caderno de Atenção Básica, , Brasil. Ministério da SaúdeBresee, J.S., Parashar, U.D., Widdowson, M.A., Gentsch, J.R., Steele, A.D., Glass, R.I., Update on Rotavirus Vaccines (2005) Pediatr Infect Dis J, 24, pp. 947-952Cortese, M.M., Parashar, U.D., (2009) Prevention of Rotavirus Gastroenteritis among Infants and Children, 58, pp. 1-25. , Recommendations of the Advisory Committee on Immunization Practices (ACIP) - CDCwww.saude.sp.gov.br/htm/hidriva/rotavirus_dados.html(2006) Secretaria de Vigilância Em Saúde, Departamento de Vigilância e Epidemiologia, Programa Nacional de Imunizações, , http://www.cve.saude.sp.gov.br/, Brasil. Ministério da Saúde. Manual dos Centros de Referência para Imunobiológicos Especiais (Cries). Disponível em acesso em 20/03/09(2008) Wkly Epim Rec, 83, pp. 37-44. , Global Advisory Committee on Vaccine Safety, 12-13 December 2007Pileggi, G.C., Souza, C.B.S., Ferriani, V.P.L., Safety and immunogenicity of varicella vaccine in patients with juvenile rheumatic diseases using methotrexate and glucocorticoids Arthritis Care Res, No PreloFeijo, R.B., Cunha, J., Krebs, L.S., Vaccination schedule for childhood and adolescence: Comparing recommendations (2006) Jornal de Pediatria, 82 (SUPPL. 1), pp. S4-S14. , http://www.jped.com.br/conteudo/06-82-S4/ing.pdf, DOI 10.2223/JPED.1498O'Neill, S.G., Isenberg, D.A., Immunizing patients with systemic lupus erythematosus: A review of effectiveness and safety (2006) Lupus, 15, pp. 778-783Heijstek, M.W., Pileggi, G.C.S., Zonneveld-Huijssoon, E., Armbrust, W., Hoppenreijs, E.P.A.H., Uiterwaal, C.S.P.M., Kuis, W., Wulffraat, N.M., Safety of measles, mumps and rubella vaccination in juvenile idiopathic arthritis (2007) Annals of the Rheumatic Diseases, 66 (10), pp. 1384-1387. , DOI 10.1136/ard.2006.063586Borte, S., Liebert, U.G., Borte, M., Sack, U., Efficacy of measles, mumps and rubella revaccination in children with juvenile idiopathic arthritis treated with methotrexate and etanercept (2009) Rheumatology, 48, pp. 144-148(2002) Pertussis, 51, pp. 73-76. , Centers for Disease Control and Prevention (CDC). United States, 1997-2000. MMWR Morb Mortal Wkly RepDe Carvalho, A.P., Pereira, E.M., Acellular pertussis vaccine for adolescents (2006) J Pediatr, 82, pp. S15-24. , Rio JCalendário Básico de Vacinação. PORTARIA N° 97/GM de 8 de Abril de 2004, , http://portal.saude.gov.br/portal/saude/visualiza_texto.cfm?idtxt=21462, Brasil, Ministério da Saúde. Disponível emPertussis vaccines - WHO position paper (2005) Wkly Epidemiol Rec, 80, pp. 31-39. , World Health OrganizationGeneral recommendations on immunization (2002) MMWR, 51, pp. 1-35. , Centers for Disease Control and Prevention. recommendations of the Advisory Committee on Immunization Practices (ACIP)Parkkali, T., Stenvik, M., Ruutu, T., Hovi, T., Volin, L., Ruutu, P., Randomized comparison of early and late vaccination with inactivated poliovirus vaccine after allogeneic BMT (1997) Bone Marrow Transplantation, 20 (8), pp. 663-668Stenvik, M., Hovi, L., Siimes, M.A., Roivainen, M., Hovi, T., Antipolio prophylaxis of immunocompromised children during a nationwide oral poliovaccine campaign (1987) Pediatric Infectious Disease Journal, 6 (12), pp. 1106-1110